# Nitric Oxide Donors for Treatment of Isolated Oligohydramnios

> **NCT02712125** · PHASE2,PHASE3 · COMPLETED · sponsor: **Benha University** · enrollment: 100 (actual)

## Conditions studied

- Isolated (Idiopathic) Oligohydramnios

## Interventions

- **DRUG:** isosorbide mononitrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02712125
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02712125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02712125, "Nitric Oxide Donors for Treatment of Isolated Oligohydramnios". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02712125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*